Infection Prevention and Control

  • Scope: NAP Countries
  • Focus: NTP
  • Objectives:
    • Describe the hierarchy of IPC controls and their respective importance
    • Describe global-level, comparable indicators as examples of measurement opportunities for IPC interventions
  • Expected Outputs/Outcomes: After attending the webinar, participants will be able to
    • Describe some high-level, comparable indicators for measuring IPC interventions in various IPC domains
      • Which of the three is a possible IPC measurement for administrative controls:
        • Percentage of people who are started on effective therapy after a TB diagnosis through a molecular test within one day
        • Percentage of health care workers wearing N95 respirators
        • Percentage of facilities in the country with an up-to-date IPC plan
      • Understand the specific, operationalized measurements of IPC interventions and hear experiences from country teams on how they measure IPC interventions at national and sub-national levels.
        • True or false, all countries can measure every IPC intervention through the same set of indicators?
          • False I would say (i.e. need local context)
        • Detailed Outline:
          • Intro/Measuring IPC Implementation/Purpose:
            • To measure progress toward NAP Milestones 2.2.1 and 2.2.3 in the 10 NAP priority countries
            • To define global comparative indicators to measure IPC implementation
            • To supplement these global indicators with additional, country-specific indicators as requirements and resources allow
            • To document progress toward NAP milestones in a standardized and comparable manner
          • Choosing Universal Indicators:
            • Methods (this is focused on the Manila meeting in August 2018 and subsequent October 2018 meeting in The Hague and the process we followed)
              • Define a detailed framework of IPC indicators
              • Within this framework, assess the current status of measuring IPC interventions in the NAP countries
              • Facilitated through the Global Consultation and Support for IPC Implementation in Manila, Philippines on August 6-7, 2018
              • Compare the county-level frameworks to understand possibilities for comparative indicators
              • Define overall, global/comparative indicators to measure progress toward NAP milestones
              • Supplement these indicators with additional, country-specific indicators as necessary and feasible
            • Present national level M&E Indicator Survey Results (i.e. when we presented the list of every IPC indicator, what countries were already collecting which?)
              • Present this by type of control (i.e. managerial, administrative, environmental, PPE and separately for HCW screening)
            • Present summary results to look at overall quantity of indicators collected on IPC in each of the NAP countries who participated
            • Present the preferred institutional level TB IPC indicators (the ones we discussed in The Hague)
          • Country Example: South Africa
          • Country Example: Ukraine (or another country based on suggestions)
          • Questions
          • Conclusion
  • Date and Time: August 15, 2019 Time – TBD

  • Scope: NAP Countries
  • Focus: NTP
  • Objectives:
    • Describe the hierarchy of IPC controls and their respective importance
    • Describe the components of an IPC roadmap and essential details for inclusion and its use as an implementation tool and measurement tool
    • Share country experience on measuring IPC interventions at different levels
  • Expected Outputs/Outcomes: After attending the webinar, participants will be able to
    • Understand the rationale behind IPC roadmaps and the necessary components for creating a strong and operational roadmap
      • Which of the following are ESSENTIAL components in an IPC roadmap:
        • Data source
        • Responsible parties for collection and analysis
        • Timeline for implementation
        • All of the above
      • Understand the specific, operationalized measurements of IPC interventions and hear experiences from country teams on how they measure IPC interventions at national and sub-national levels.
        • True or false, all countries can measure every IPC intervention through the same set of indicators?
          • False I would say (i.e. need local context)
        • Detailed Outline:
          • Intro/Measuring IPC Implementation/Purpose:
            • To measure progress toward NAP Milestones 2.2.1 and 2.2.3 in the 10 NAP priority countries
            • To discuss the use of IPC roadmaps for institutionalizing data collection and use
            • To document progress toward NAP milestones in a standardized and comparable manner
          • Developing an Implementation Roadmap
            • Core components:
              • New or Existing: is the indicator already in use?
              • Data Source: what data systems are used to collect data for this indicator?
              • Responsible Parties: who (at each level) is responsible for data collection, aggregation, analysis and presentation?
              • Frequency: How frequently is this indicator reported?
              • Timeline: for new indicators, when will the indicator be in use and reported?
            • Levels of Implementation:
              • Most indicators are facility level indicators (with aggregation to various higher levels for reporting purposes)
              • National level indicators could include the following
              • Incidence of TB infection among health care workers
              • National TB infection control guideline scorecard
            • Operationalizing the Roadmap
              • Assess current indicators in the country
              • Which of the universal indicators are currently in place?
              • For new indicators, follow the “essential elements” to define a plan for implementing
              • Define a baseline for new indicators
              • Use the full set of universal indicators to report progress toward NAP milestones in a standardized, comparable manner
            • Country Example: South Africa
            • Country Example: Ukraine (or another country based on suggestions)
            • Questions
            • Conclusion
  • Date and Time: September 4, 2019 Time – TBD

  • Scope: NAP Countries
  • Focus: NTP
  • Objectives:
    • Describe certain risk determinants of TB relevant to healthcare workers
    • Describe existing IPC interventions aimed at reducing risk of TB transmission among healthcare workers
    • Describe measurement methods for understanding healthcare worker TB incidence (infection and active disease) and for monitoring and evaluating general IPC program effectiveness
    • Discuss existing country-level examples of HCW surveillance systems
  • Expected Outputs/Outcomes: After attending the webinar, participants will be able to
    • Describe TB transmission risks which are relevant to healthcare workers
      • Which types of health care workers are susceptible to TB acquisition
        • Clinical workers (doctors, nurses)
        • Administrative staff (cleaners, managers)
        • Both
      • Describe IPC interventions relevant to healthcare workers
        • Which of the following is an administrative control relevant to health care workers:
          • FAST
          • Training
          • Fit testing
        • Describe measurement, monitoring and evaluation methods for IPC programs with a focus on healthcare worker TB infection and TB disease
          • Which indicator can be used as a proxy for TB incidence:
            • Health care worker incidence compared to general incidence
            • Proportion of health care workers receiving a fit test
            • Proportion of health care workers trained in TB management
          • Detailed Outline:
            • Introduction/Purpose
              • Describe healthcare workers’ risk for TB and how this is higher than the general population
              • Describe IPC in the context of healthcare workers (i.e., what interventions are in place, what do we use to measure implementation and what is the path forward)
              • Describe using HCW incidence as a marker for general IPC implementation (i.e., if HCW incidence = incidence of the general population, facility-based IPC implementation is good)
            • Healthcare worker Risk
              • Duration/intensity of exposure
              • Not just in TB wards
              • Describe diagnostic tools here as well
                • TST
                • IGRA
              • IPC in the context of healthcare workers
                • Managerial:
                  • Training
                  • IPC committees
                • Administrative:
                  • FAST
                    • % healthcare workers screened for active TB disease
                    • % healthcare workers tested for LTBI
                  • Environmental:
                    • Sputum collection
                    • Waiting areas
                  • PPE:
                    • Fit testing for respirators
                  • Measuring IPC implementation through HCW incidence
                    • Concept: if incidence (HCW) = incidence (all), IPC implementation is good
                    • How to test HCWs? (IGRA, TST etc – benefits and challenges for both)
                    • How to report this?
                      • Capacity, quality etc
                    • Questions
                    • Conclusions
      • Date and Time: August 8, 2019 Time – TBD

  • Scope: 24 Priority countries + Global?
  • Focus: NTP, NGOs, civil society?
  • Objectives:
    • Describe the FAST approach to infection control
    • Describe FAST in the context of updated WHO guidelines
    • Describe measurement, monitoring and evaluation of FAST
  • Expected Outputs/Outcomes: After attending the webinar, participants will be able to
    • Describe the concepts behind FAST
      • Which of the following is NOT a FAST concept:
        • Screening upon entry
        • Immediate contact tracing
        • Prompt testing with molecular diagnostics
      • Describe measurement, monitoring and evaluation aspects of FAST
        • Which is an example process indicator for measuring FAST
          • Proportion of patients screened for active TB disease upon hospital entry
          • Proportion of presumptive patients given a mask
          • Proportion of all confirmed TB contacts tested
        • Understand how FAST concepts fit into the updated WHO guidelines
          • Are FAST principles included in the updated WHO IPC guidelines?
            • Yes
          • Detailed Outline:
            • Introduction/Purpose:
              • Describe the FAST approach at a high level
                • Country examples
              • Describe FAST in the context of new WHO guidelines and as a way to implement administrative controls
              • Describe the measurement, monitoring and evaluation of FAST
            • An overview of FAST
              • Finding cases Actively
                • Deliver a symptom screen for each person entering a facility
              • Separating Safely
                • For those screening presumptive for TB, move to a separate waiting area
              • Treating Effectively
                • For those who are presumptive, collect sputum for a molecular test (usually GeneXpert)
                • Deliver results quickly (<2 days) and begin appropriate therapy (taking into account the patient’s drug resistance profile)
              • FAST as an administrative control approach
                • Can work to identify TB patients who would be missed by the health system otherwise
                  • e., in HIV wards, antenatal care wards, staff clinics etc (i.e., not TB wards)
                • Can deliver more effective therapy through universal drug resistance profiling
                • Can initiate people on treatment more quickly through rapid molecular tests like GXP
              • Measuring, monitoring and evaluating FAST
                • Facility level
                  • % of hospitalized patients screened for active TB
                  • % of presumptive patients tested for TB with GXP
                  • % of presumptive patients tested for TB with GXP within one day of admission
                    • Ideally collect admission and test date to derive actual number of days
                  • % of those testing positive for TB who initiate appropriate therapy
                • National level
                  • % of facilities with:
                    • > 90% patients screened for active TB
                    • >90% presumptive patients tested for active TB with Xpert
                    • >90% of presumptive patients tested for active TB with Xpert within 1 day of admission
                    • >90% confirmed patients started on appropriate therapy
                  • Could add something about cost per patient identified
                • Country example: Implementing FAST in South Africa
                  • Initial rollout
                    • Describe ward level screening
                  • Scale up
                  • Measurement
                    • Focus on data analytics and on TAT calculation
                  • Plans for future expansion
                • Questions
                • Conclusions
  • Date and Time: July 25, 2019 Time – TBD

  • Scope: 24 Priority countries + Global?
  • Focus: NTP, NGOs, etc
  • Objectives:
    • Describe the concept of UVGI
    • Describe UVGI in the context of updated WHO guidelines
    • Describe split air conditioning units and the role of UVGI in reducing TB transmission in these settings
  • Expected Outputs/Outcomes: After attending the webinar, participants will be able to
    • Describe the concept of UVGI including implementation, monitoring and evaluation
      • What is UVGI?
        • A supplemental environmental control to ventilation methods
        • A standalone environmental control measure
        • An administrative control
      • Describe the relevant WHO guidelines
        • Are UVGI concepts included in the WHO guidelines?
          • Yes
        • Describe split AC units, associated TB transmission risks and the role of UVGI in reducing TB transmission
          • Are split AC units helpful for TB control?
            • No
          • Detailed Outline
            • Intro/Purpose
              • Describe environmental controls, especially natural ventilation and UVGI
              • Describe UVGI (esp as an essential supplement to natural vent.)
              • Measuring UVGI implementation
              • Make a case example of ductless/split AC and the growing urgency of GUV implementation
            • Environmental Controls
              • Natural ventilation
                • Pros
                • Cons
              • GUV
                • Pros
                • Cons
              • Not an either/or, but rather supplemental/complementary
            • Measuring UVGI implementation
              • Discuss available indicators
              • Discuss challenges/successes in measuring UVGI
            • Case example: Ductless/split AC and the need for UVGI
              • Split/ductless AC recycles air in the given space (i.e. a waiting room)
                • Describe the data on this
                • Describe the specific UVGI solution (upper room!)
              • Describe cost effectiveness of GUV compared to other air cleaners
            • Way forward: GUV as an essential environmental control
              • Advances, research etc.
              • Safety
            • Questions
            • Conclusions
  • Date and Time: July 30, 2019 Time – TBD

 

Comprehensive Supportive Care for People with DR-TB

  • Scope: 24 Priority Countries, Global
  • Focus: NTP, NGOs, civil society, incl patients groups
  • Objectives:
    • Provide an overview of the NAP and the comprehensive care package for DR-TB
    • Describe the Pilot objectives and intended outcomes
    • Describe the contextual adaptation and implementation of the comprehensive care package by pilot country
    • Share early lessons learned from each of the pilot countries (China, Pakistan, South Africa, Ukraine)
  • Expected Outputs/Outcomes: After attending the webinar, participants will be able to
    • Describe the component objectives of the NAP
    • Understand the need for adaptation and implementation based on country context
    • Poll questions:
  • Why is it important to implement a comprehensive care package for patients with DR-TB?
    • essential to prevent suffering and death from TB and to reduce transmission
    • Improve access to TB treatment
      • What are the thematic areas of the comprehensive care package?
        • Respect patient autonomy and improve self-efficacy, maximize physical comfort, safety, and wellness, provide psycho-emotional support and protection from social isolation or discrimination, prevent catastrophic costs to patient and family
        • Respect patient autonomy and improve self-efficacy, provide psycho-emotional support and protection from social isolation or discrimination, prevent catastrophic costs to patient and family
        • Respect patient autonomy and improve self-efficacy, maximize physical comfort, safety, and wellness, provide psycho-emotional support and protection from social isolation or discrimination
  • Detailed Outline:
    • Comprehensive supportive care package framework
      • Thematic areas and components
      • Operationalizing the framework at national, facility and patient level
      • Care package guidance documents
    • Pilot Project overview
      • Objectives
      • Timelines
      • Examples of package implementation in country
      • Pilot design, adapted implementation package, implementation focus
        • South Africa
        • Ukraine
        • China
        • Pakistan
    • Pilot results and lessons learned from countries
      • Patients’ perception of care package
      • Treatment outcomes from pilot
      • Patient satisfaction with care package
      • Implementation challenges and lessons learned
    • Q&A
    • Conclusion
  • Date and Time: August 6, 2019 Time – TBD

  • Scope: 24 Priority Countries, Global?
  • Focus: NTP, National Program Managers
  • Objectives:
    • Rationale for a comprehensive care package programming
    • Describe the framework and components of the comprehensive care package
    • Describe the step-by-step approach to implementing care package at the national level
    • Describe the tools and their use for implementing care package
  • Expected Outputs/Outcomes: After attending the webinar, participants will be able to
    • Understand the rationale for implementing the comprehensive care package for DR-TB
    • Understand the overall framework and components of comprehensive care package
    • Understand the need for adaptation and implementation based on country context
    • Understand the steps for designing and implementing the care package adapted to the country context
    • Develop capacity to use How-To Guide and tools to design, implement and monitor care package
    • Poll questions:
  • Why is it important to implement a comprehensive care package for patients with DR-TB?
    • essential to prevent suffering and death from TB and to reduce transmission
    • Improve access to TB treatment
      • What are the thematic areas of the comprehensive care package?
        • Respect patient autonomy and improve self-efficacy, maximize physical comfort, safety, and wellness, provide psycho-emotional support and protection from social isolation or discrimination, prevent catastrophic costs to patient and family
        • Respect patient autonomy and improve self-efficacy, provide psycho-emotional support and protection from social isolation or discrimination, prevent catastrophic costs to patient and family
        • Respect patient autonomy and improve self-efficacy, maximize physical comfort, safety, and wellness, provide psycho-emotional support and protection from social isolation or discrimination
  • Detailed Outline:
    • Rationale for the DR-TB care package
      • Current DR-TB situation
      • Link to the SDGs and UHC
    • Framework for delivering DR-TB care package
      • General overview of framework
      • Thematic areas and their components
      • Operationalizing the framework at national, facility and patient level
    • Step-by-step approach to implementing DR-TB supportive care package
      • Care package guidance documents
      • The 10-step process for introducing supportive care package at the national level
      • Introduction to each step
    • Operational Toolkit for designing supportive care package at the national level
      • Introduction to tools
    • Q&A
    • QUIZ for learning assessment
    • Conclusions
  • Date and Time: August 13, 2019 Time – TBD

  • Scope: 24 Priority Countries, Global
  • Focus: Facility Level Managers, Civil Society Organizations (CSOs)
  • Objectives:
    • Rationale for a comprehensive care package programming
    • Describe the framework and components of the comprehensive care package
    • Describe the step-by-step approach to implementing care package at the facility and patient level
    • Describe the tools and their use for implementing the care package
  • Expected Outputs/Outcomes: After attending the webinar, participants will be able to
    • Understand the rationale for implementing the comprehensive care package for DR-TB
    • Understand the overall framework and components of comprehensive care package
    • Understand the need for adaptation and implementation based on country context
    • Understand the design steps for implementing the care package at country level
    • Develop capacity to use How-To Guide and tools to design and implement care package
    • Poll questions:
  • Why is it important to implement a comprehensive care package for patients with DR-TB?
    • essential to prevent suffering and death from TB and to reduce transmission
    • Improve access to TB treatment
      • What are the thematic areas of the comprehensive care package?
        • Respect patient autonomy and improve self-efficacy, maximize physical comfort, safety, and wellness, provide psycho-emotional support and protection from social isolation or discrimination, prevent catastrophic costs to patient and family
        • Respect patient autonomy and improve self-efficacy, provide psycho-emotional support and protection from social isolation or discrimination, prevent catastrophic costs to patient and family
        • Respect patient autonomy and improve self-efficacy, maximize physical comfort, safety, and wellness, provide psycho-emotional support and protection from social isolation or discrimination
  • Detailed Outline:
    • Rationale for the DR-TB care package
      • Patient and community perspectives
    • Framework for delivering DR-TB care package
      • General overview of framework
      • Thematic areas and their components
      • Operationalizing the framework at national, facility and patient level
    • Step-by-step approach to implementing DR-TB care package at the facility and patient level
      • Care package guidance documents
      • Principles of patient-centered case management
      • The 3-step process for supportive care package implementation at the facility and patient level
      • Introduction to each step
    • Operational Toolkit for designing supportive care package at the national level
      • Introduction to tools
    • Q&A
    • QUIZ for learning assessment
    • Conclusions
  • Date and Time: August 20, 2019 Time – TBD

  • Scope: 24 Priority Countries
  • Focus: National Program Managers, Facility Level Managers, Civil Society Organizations (CSOs)
  • Objectives:
    • Describe the framework and components of the comprehensive care package
    • Provide an overview of the benefits of implementing the DR-TB care package
    • Describe the role advocacy plays in the implementation of the DR-TB care package.
    • Describe the advocacy tools and their use for implementing the care package
  • Expected Outputs/Outcomes: After attending the webinar, participants will be able to
    • Understand the overall framework and components of comprehensive care package
    • Understand the need for adaptation and implementation based on facility context
    • Understand the role advocacy plays in supporting the implementation of the DR-TB care package
    • Develop capacity to use How-To Guide and tools to design, implement and monitor care package at the facility level
    • Poll questions:
  • Why is it important to implement a comprehensive care package for patients with DR-TB?
    • essential to prevent suffering and death from TB and to reduce transmission
    • Improve access to TB treatment
      • What are the thematic areas of the comprehensive care package?
        • Respect patient autonomy and improve self-efficacy, maximize physical comfort, safety, and wellness, provide psycho-emotional support and protection from social isolation or discrimination, prevent catastrophic costs to patient and family
        • Respect patient autonomy and improve self-efficacy, provide psycho-emotional support and protection from social isolation or discrimination, prevent catastrophic costs to patient and family
        • Respect patient autonomy and improve self-efficacy, maximize physical comfort, safety, and wellness, provide psycho-emotional support and protection from social isolation or discrimination
  • Detailed Outline:
    • Framework for delivering DR-TB care package
      • Rationale for the Comprehensive care package
      • General overview of framework
        • Thematic areas and their components
    • Operationalizing/implementing the framework at national, facility and patient level
    • Role of CSO in the operationalization of the framework
      • Advocacy and Social Mobilization
      • Community Engagement
      • Communication for Social Change
    • Monitoring Advocacy efforts
      • Introduction to tools (Advocacy and Social Mobilization Plan, M&E plan)
    • Q&A
    • Conclusions
  • Date and Time: August 27, 2019 Time – TBD

 

Community-Based DR-TB Care

  • Scope: NAP Countries, 24 Priority Countries, Global
  • Focus: NTP and Civil Society
  • Objectives:
    • Describe the different models of DR-TB care provision
      • What models are there for DR-TB care provision
        • Hospital, Ambulatory, community
    • Describe operational considerations for different models of DR-TB care
  • Expected Outputs/Outcomes: After attending the webinar, participants will be able to
    • Describe community-based, ambulatory and hospital-based DR-TB care models
    • Understand various operational considerations for the different DR-TB care models
    • Understand the cost-effectiveness of different models
  • Detailed outline:
    • Models of DR-TB care provision
      • DR-TB Patient Pathway from diagnosis to treatment
      • Principles of patient-centered care
      • Where should the patient be treated – hospital, ambulatory, community
      • Rationale for different models of care
      • Model of care appropriate for your context
    • Operational considerations for different models of care
      • Hospital-based care
      • Ambulatory care
      • Community-based care
    • Cost-effectiveness of different models of care
      • Treatment outcomes
      • Cost of care
    • Q&A
    • Conclusion
  • Date and Time: September 3, 2019 Time – TBD

  • Scope: 24 Priority Countries, Global
  • Focus: NTP and Civil Society
  • Objectives:
    • Describe the context and rationale for community-based DR-TB care
    • Describe the framework for community-based DR-TB care
    • Discuss operational consideration for community-based DR-TB care both clinical and supportive aspects
    • Discuss best practices in community-based DR-TB care
  • Expected Outputs/Outcomes: After attending the webinar, participants will be able to
    • Learn about the framework for community-based DR-TB care
    • Understand the different components of community-based DR-TB care
    • Gain knowledge about the steps for implementing community-based DR-TB care aspects
  • Detailed outline:
    • Context and rationale for community-based DR-TB care
      • Current state of DR-TB management
      • Ensuring patient-centered care
      • Advantages of community-based care
    • Framework for community-based DR-TB care
      • Components of community-based care
        • Clinical components
        • Non-clinical components
    • Operational considerations for community-based care
      • Policy and guidelines for community-based care
      • Adapting package of care to local context
      • Staff capacity development
      • Develop multi-sectoral linkage to ensure supportive care
      • Referral linkage for diagnostic and clinical follow-up
      • Monitoring and evaluation
    • Best practices in community-based DR-TB care
      • Country examples
    • Q&A
    • QUIZ for learning assessment
    • Conclusion
  • Date and Time: September 10 2019 Time – TBD

 

Digital Technology for TB and DR-TB

  • Scope: 24 Priority Countries
  • Focus: NTP
  • Objectives:
    • Introduce the WHO handbook on digital technology for TB and DR-TB
    • Describe the aspects of the Digital Technology for a World Free of Tuberculosis guidance document
    • Describe the steps for developing digital health agenda and roadmap
  • Expected Outputs/Outcomes: After attending the webinar, participants will be able to
    • Understand the WHO handbook on digital technology for TB and DR-TB
    • Learn about the aspects of Digital Technology for a World Free of TB guidance document
      • Which is the initial step in implementing digital health for TB Control
        • Situational analysis
        • Priority Setting
        • Stakeholder identification
    • Describe the steps for developing digital technology in their specific country context
  • Detailed outline:
    • Context and Rationale of Digital Health Technology
      • Background
      • Overview
      • Role of digital technology in TB control
      • TB patient pathway
    • Setting Digital Health Agenda and Roadmap – key components
      • Essential steps to developing digital health agenda
      • Stakeholder identification
      • Situational analysis
      • Priority setting
      • Cost-benefit analysis
      • Integrating monitoring and evaluation
      • Pilot testing
    • WHO digital health guidance
    • Country implementation experience
      • South Africa
      • India
    • Q&A
    • Conclusion
  • Date and Time: September 17, 2019 Time – TBD

  • Scope: 24 Priority Countries, Global
  • Focus: NTP, Civil Society, local IT organizations
  • Objectives:
    • Discuss the rationale for digital app to improve DRTB treatment adherence
    • Describe the key operational considerations for selection of appropriate digital solutions (system support, hardware, internet connectivity, human resource, etc)
    • Describe the steps to developing the app for DRTB treatment adherence
  •  Expected Outputs/Outcomes: After attending the webinar, participants will be able to
    • Understand the operational considerations for different digital solutions
    • Understand the steps for developing the app for DRTB treatment adherence
    • Know about country experience with use of apps for improving treatment adherence
  • Detailed outline:
    • Rationale of Digital Health Technology
      • Role of digital technology in TB control
      • Current situation in DRTB treatment adherence
    • Key consideration for selecting appropriate digital solutions for monitoring treatment adherence
      • Systems needs for apps to function
      • Different options for apps
      • Identifying the scope of treatment adherence
      • Priority setting
      • App design
      • Human resource development
      • System support and maintenance
      • Pilot testing
      • Scale up
    • Country implementation experience
      • South Africa
      • India
    • Q&A
    • Conclusion
  • Date and Time: September 24, 2019 Time – TBD

  • Scope: 24 Priority Countries
  • Focus: NTP
  • Objectives:
    • Describe relevant mHealth interventions
  • Expected Outputs/Outcomes: After attending the webinar, participants will be able to
    • Describe relevant mHealth interventions and apply these to their specific country contexts
  • Detailed Outline:
    • Introduction
    • Describe this webinar (VDOT) as one in a series of digital health intervention webinars in which we highlight a specific type of intervention and describe a variety of details
    • Webinar format
    • Describe the intervention
      • Video-DOT (VDOT) is a telemedicine technology which allows patients to complete DOT through the use of videoconferencing software rather than physical visits from a care worker
      • Why is this innovative?
      • Human resources constraints: reduces HR constraints by allowing one care worker to monitor more patients
      • Cost could be cheaper through reduced transport costs
      • Stigma reduction: reduces possibility for stigma, i.e., if neighbors notice a care worker going to someone’s house every day they may mention it to their neighbors
      • Geographical considerations: can more easily reach people in remote areas where there is cellular coverage but no easily accessible health center
    • Cost/benefit:
      • Reduces transport costs for HCWs and patients, adds cost of airtime/devices
    • Country implementation examples
      • India? South Africa? Need to review possibilities
    • Q&A
    • Conclusion
  • Date and Time: October 3, 2019 Time – TBD

  • Scope: Global
  • Focus: NTP and Civil Society (two outlines below)
  • Objectives:
    • Describe the IPConnect tool and the various available modules
    • Explain the functionalities of IPConnect through a South African case example
    • Describe the adaptability of IPConnect and flexibility within each module to highlight the versatility of the platform for implementation in other countries
  • Expected Outputs/Outcomes: After attending the webinar, participants will be able to
    • Describe the various IPConnect modules and their importance for holistic IPC in a facility setting
      • IPConnect is useful for the following groups
        • Clinical healthcare workers
        • Facility managers
        • Program managers
        • All of the above
      • Understand the success of IPConnect implementation in South Africa
        • Can’t think of a question for this for pre/post, but post:
          • South Africa has adapted IPConnect to include which novel intervention
            • CO2 Monitors
            • Guideline repository
            • Facility risk assessments
          • Describe which elements of IPConnect would be best suited for their country’s specific IPC programming and understand the level of flexibility for country-specific adaptation
            • This is more open ended I think
  • NTP-Focused Detailed Outline:
    • Intro/Purpose/IPConnect Overview
      • To describe the IPConnect suite of applications and their utility in implementing infection prevention and control programs
      • To apply this description to the South African context as an example of how IPConnect is used in programmatic settings
    • IPConnect: Core Elements
      • Show homepage
      • Show all core elements (8)
      • Show the five main functions/aims of IPConnect achieved by the eight core modules:
        • Facility-specific IPC gaps, both physical and knowledge
        • Focused response actions
        • Mass distribution of guideline updates, trainings, and other information, education and communication (IEC) materials
        • Real-time data for immediate and accurate action.
        • Comprehensive data collection of IPC risks, responses, and guidelines allow staff to ensure appropriate provision of resources and tailored trainings and supervision activities.
      • IPConnect Implementation in South Africa:
        • IPConnect-SA homepage
        • Core elements of IPConnect in SA
          • The South African IPConnect implementation includes the following core elements:
          • Facility risk assessments
            • With summary dashboard
          • Home-based risk assessments
          • CO2 monitor dashboards
          • Guideline repository for staff use
        • For each core element describe in detail the focus of implementation and show some results
          • Facility Risk Assessments
            • Show data collection page/describe process
            • Show an example dashboard
          • Home-based risk assessments
            • Show the data collection page/describe process
            • Show available summary data
          • CO2 monitors
            • Show the dashboard page, describe the general data process as well
          • Guideline repository
            • Show the guideline page
            • Show how guidelines are updated
            • Show the mobile app for staff access
            • Describe the push notification system for daily tips
          • Questions
          • Conclusion
  • Civil Society-Focused Detailed Outline:
    • Intro/Purpose/IPConnect Overview
      • To describe the IPConnect suite of applications and their utility in implementing infection prevention and control programs
      • To apply this description to the South African context as an example of how IPConnect is used in programmatic settings
      • For the civil society focused webinar, to place a greater focus on staff capacity building and the use of IPConnect as a job aid for improving IPC practices
    • IPConnect: Core Elements
      • Show homepage
      • Show all core elements (8)
      • Show the five main functions/aims of IPConnect achieved by the eight core modules:
        • Facility-specific IPC gaps, both physical and knowledge
        • Focused response actions
        • Mass distribution of guideline updates, trainings, and other information, education and communication (IEC) materials
        • Real-time data for immediate and accurate action.
        • Comprehensive data collection of IPC risks, responses, and guidelines allow staff to ensure appropriate provision of resources and tailored trainings and supervision activities.
      • IPConnect as a capacity-building tool and a job aid
        • Incident reporting:
          • Describe this module in detail, in which staff are able to report incidents anonymously or with identifiers attached and in which staff can report infection outbreaks
          • IPC Guidelines:
            • Describe the use of IPConnect as a guideline repository, and focus on the use of the mobile app to allow staff to have guidelines available at their fingertips
            • Case-Specific Queries:
              • Describe the question/answer function of IPConnect as an interactive job aid
            • Push Notifications:
              • Describe the function of this module as a way for administrators to push updates or IPC tips to staff
            • IPC FAQ
              • Describe this module and its use in answering frequently asked questions staff may have
              • Client Feedback
                • Describe this as a useful tool for civil society to monitor quality and implementation of IPC practices in various locations and facilities etc
                • IPConnect Implementation in South Africa:
                  • IPConnect-SA homepage
                  • Core elements of IPConnect in SA
                    • Focus this discussion on guideline repositories and any other feedback modules in place
                    • The South African IPConnect implementation includes the following core elements:
                    • Facility risk assessments
                      • With summary dashboard
                    • Home-based risk assessments
                    • CO2 monitor dashboards
                    • Guideline repository for staff use
                  • For each core element describe in detail the focus of implementation and show some results
                    • Guideline repository
                      • Show the guideline page
                      • Show how guidelines are updated
                      • Show the mobile app for staff access
                      • Describe the push notification system for daily tips
                    • Questions
                    • Conclusion
  • Date and Time: October 15, 2019 Time – TBD

  • Scope: Global
  • Focus: NTP
  • Objectives:
    • Describe relevant mHealth interventions
  • Expected Outputs/Outcomes: After attending the webinar, participants will be able to
    • Describe relevant mHealth interventions and apply these to their specific country contexts
      • Which of the following is NOT a function of ConnecTB:
        • Adherence support
        • Side effect monitoring
        • Geomapping
        • Direct patient SMS communicatoin
  • Detailed outline:
    • Context and Rationale
      • Background and Objectives
      • Benefits of using digital technology in TB management
      • Digital technology to streamline TB care
      • Why ConnecTB for case management
    • Components of ConnecTB
      • Geo-Mapping
      • Patient retention – ConnecTB application
      • ConnecTB workflow
      • Countries using ConnecTB
    • Country experience
      • South Africa
        • Realtime DOT status monitoring
        • Remote supervision
        • Daily Alerts
        • TB Patient Retention Results
        • Identifying TB hotspots for case detection
        • Contact Tracing
      • Bangladesh experience
    • Way Forward
    • Q&A
    • Conclusion
  • Date and Time: October 24, 2019 Time – TBD

 

DESTRoy TB initiative

  • Scope: 24 Priority Countries
  • Scope: 24 Priority Countries + Global
  • Focus: NTP
  • Objectives:
    • Describe the global MDR/RR-TB treat and challenges
    • Describe the revised guidelines for treatment of MDR/RR-TB
    • Provide information on the DESTRoy TB Operational Research Initiative
    • Describe the steps for scaling up implementation of modified guidelines for treatment of MDR/RR-TB
  • Expected Outputs/Outcomes: After attending the webinar, participants will be able to
    • Understand the aspects of the DESTRoy TB Operational Research activities
    • Inform about the modified guidelines for treatment of MDR/RR-TB
    • Understand the steps for planning implementation of modified guidelines
  • Detailed Outline:
    • Introduction
      • Global MDR/RR-TB situation
      • Challenges with MDR/RR-TB treatment
    • Modified guidelines for treatment of MDR/RR-TB
      • Updated treatment regimen
      • Key aspects of updated guidelines
    • DESTRoy TB Operational Research Initiative
      • Objectives
      • Methodology
      • Implementation design
      • Results update
    • Scaling up implementation of modified treatment guidelines for MDR/RR-TB
      • Implementation planning for local context
      • Policy implications
      • Resource mobilization
      • Systems strengthening
        • Human resource development
        • Monitoring and Evaluation
      • Q&A
      • Conclusion
  • Date and Time: October 29, 2019 Time – TBD